Julie Andrews, Director at RxSight, Inc. (RXST), bought 23,270 shares at $16.00 ($250K) on 2021-08-03, disclosed to the SEC on 2021-08-05.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 7,645 | $0 | 0.0% |
| 2 | $16.00 | 15,625 | $250K | 100.0% |
| Total | $10.74 avg | 23,270 | $250K | 100% |
| Filing → |
| OFIX | SELL | 2025-01-21 | $167K | — | Filing → |
| RXST | SELL | 2024-06-17 | $1.8M | — | Filing → |
| WMGI | SELL | 2020-08-19 | $33K | — | Filing → |